Suppr超能文献

3'-叠氮-3'-脱氧胸苷(AZT)与ICI D1694的联合研究。细胞毒性和生化效应。

Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects.

作者信息

Pressacco J, Erlichman C

机构信息

Division of Experimental Therapeutics, Ontario Cancer Institute, Toronto, Canada.

出版信息

Biochem Pharmacol. 1993 Dec 3;46(11):1989-97. doi: 10.1016/0006-2952(93)90641-9.

Abstract

The cytotoxicity of 3'-azido-3'-deoxythymidine (AZT), a thymidine analogue, and ICI D1694, a folate-based thymidylate synthase (TS) inhibitor, was examined individually and in combination in two human tumor cell lines, MGH-U1 bladder cancer and HCT-8 colon cancer cells, grown as a monolayer culture with and without thymidine (TdR). In addition, TS inhibition, [3H]AZT incorporation into DNA, [3H]AZT-MP (monophosphate) production, and DNA double-strand breaks were measured. Twenty-four hour exposure of AZT at 0.5, 5, 50 and 500 microM was not cytotoxic to MGH-U1 or HCT-8 cells in a colony-forming assay. ICI D1694 cytotoxicity increased with drug concentration, and the IC50 and IC90, respectively, were 0.0064 and 0.01 microM in MGH-U1 cells and 0.009 and 0.018 microM in HCT-8 cells. TdR in concentrations of 0.1 to 1.0 microM did not affect ICI D1694 cytotoxicity in either cell line. AZT at 5, 50 or 500 microM increased ICI D1694 cell kill. The IC50 and IC90 for MGH-U1 were 0.0037 and 0.0075 microM for 50 microM AZT combined with ICI D1694. The IC50 and IC90 for HCT-8 were 0.0075 and 0.015 microM for 50 microM AZT plus ICI D1694. The incorporation of [3H]AZT into DNA increased with increasing concentrations of ICI D1694. Concentrations producing an IC50 and IC90 of ICI D1694, respectively, increased incorporation of [3H]AZT into DNA by 319 and 569% in MHG-U1, and 243 and 400% in HCT-8 cells. The formation of [3H]AZT-MP paralleled the increase in [3H]AZT incorporated into DNA. AZT, ICI D1694 and the combination of AZT and ICI D1694 caused DNA double-strand breaks, with the combination of these agents being additive. CFU-GM survival, exposed to drug concentrations, as those used in the tumor cell lines, revealed that the therapeutic index was greater for AZT plus ICI D1694 than for ICI D1694 alone. These findings suggest that AZT plus ICI D1694 may increase antitumor effect with minimal myelosuppression. We conclude that AZT increases the cytotoxicity of ICI D1694 with increasing AZT incorporation into DNA.

摘要

在有无胸腺嘧啶核苷(TdR)的情况下,以单层培养方式培养了两种人类肿瘤细胞系,即MGH-U1膀胱癌细胞和HCT-8结肠癌细胞,分别单独检测了胸苷类似物3'-叠氮-3'-脱氧胸苷(AZT)以及基于叶酸的胸苷酸合成酶(TS)抑制剂ICI D1694的细胞毒性,并检测了二者联合使用时的细胞毒性。此外,还测定了TS抑制、[3H]AZT掺入DNA、[3H]AZT-单磷酸(AZT-MP)的产生以及DNA双链断裂情况。在集落形成试验中,0.5、5、50和500微摩尔的AZT暴露24小时对MGH-U1或HCT-8细胞无细胞毒性。ICI D1694的细胞毒性随药物浓度增加而增加,在MGH-U1细胞中,IC50和IC90分别为0.0064和0.01微摩尔,在HCT-8细胞中分别为0.009和0.018微摩尔。浓度为0.1至1.0微摩尔的TdR对两种细胞系中ICI D1694的细胞毒性均无影响。5、50或500微摩尔的AZT可增强ICI D1694对细胞的杀伤作用。50微摩尔AZT与ICI D1694联合使用时,MGH-U1的IC50和IC90分别为0.0037和0.0075微摩尔。50微摩尔AZT加ICI D1694时,HCT-8的IC50和IC90分别为0.0075和0.015微摩尔。随着ICI D1694浓度增加,[3H]AZT掺入DNA的量也增加。分别产生ICI D1694的IC50和IC90的浓度,使[3H]AZT掺入MHG-U1细胞DNA的量增加了319%和569%,使[3H]AZT掺入HCT-8细胞DNA的量增加了243%和400%。[3H]AZT-MP的形成与[3H]AZT掺入DNA的增加情况平行。AZT、ICI D1694以及AZT与ICI D1694的组合均导致DNA双链断裂,且这些药物的组合具有相加作用。暴露于与肿瘤细胞系中使用的药物浓度相同的药物浓度下,CFU-GM存活率显示,AZT加ICI D1694的治疗指数高于单独使用ICI D1694。这些发现表明,AZT加ICI D1694可能在最小化骨髓抑制的情况下增强抗肿瘤作用。我们得出结论,随着AZT掺入DNA的增加,AZT增强了ICI D1694的细胞毒性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验